M&A

Incyte sinks on setback for drugs acquired in $750M buyout
BioPharma Dive
Tue, 11/19/24 - 07:10 pm
Incyte
Escient Pharma
M&A
Why Merck rolled the dice on an ‘unbelievable’ early-stage brain cancer drug
Pharma Voice
Mon, 11/18/24 - 11:12 am
Merck
Modifi Biosciences
M&A
glioblastoma
brain cancer
Boston Sci Closes Acquisition of Medtronic’s Neuromodulation Foe
Medical Devices and Diagnostics Industry
Fri, 11/15/24 - 11:10 am
Boston Scientific
Medtech
Axonics
neuromodulation
M&A
BMS, Merck, Amgen and more must look to M&A to offset looming patent lapses: Leerink
Fierce Pharma
Wed, 11/13/24 - 09:49 pm
M&A
Bristol Myers Squibb
Amgen
patent cliffs
BioNTech to buy Biotheus, gaining control of cancer bispecific
BioPharma Dive
Wed, 11/13/24 - 11:30 am
BioNTech
M&A
Biotheus
Summit Therapeutics
cancer bispecifics
Pfizer explores sale of hospital drugs unit
CNBC/Reuters
Tue, 11/12/24 - 11:19 am
Pfizer
M&A
hospital drugs
Starboard Value
Pfizer Hospital
Cigna confirms it is not pursuing Humana acquisition
BioPharma Dive
Mon, 11/11/24 - 11:29 am
Cigna
Humana
M&A
insurers
Among 2024’s modest M&A action, cancer, immunology and neuroscience deals trickle in
Pharma Voice
Thu, 11/7/24 - 11:12 am
M&A
Vertex Pharmacuticals
Alpine Immune Sciences
Eli Lilly
Morphic
Novartis
MorphoSys
Mariana Oncology
AstraZeneca
Fusion Pharmaceuticals
Lundbeck
Longboard Pharmaceuticals
AbbVie
Aliada Therapeutics
Swiss biotech inks reverse merger with GI-focused Renexxion
Fierce Biotech
Mon, 11/4/24 - 07:00 pm
M&A
Relief Therapeutics
Renexxion
reverse merger
Backlash builds against Novo’s Catalent takeover
Pharma Voice
Wed, 10/30/24 - 11:40 am
Novo Holdings
Novo Nordisk
Catalent
M&A
Roche
Novartis' $2.9B MorphoSys bet stumbles as safety signal delays filing by years
Fierce Biotech
Tue, 10/29/24 - 11:44 am
Novartis
MorphoSys
M&A
AML
pelabresib
AbbVie doubles down on Alzheimer’s with $1.4B Aliada buy
BioSpace
Mon, 10/28/24 - 11:41 am
AbbVie
M&A
Alzheimer's disease
Aliada Therapeutics
Why pharma megamergers may become a relic of the past
Pharma Voice
Thu, 10/24/24 - 09:49 am
M&A
FTC
megamergers
Roche CEO says Novo's Catalent buyout 'could be a problem' for smaller drugmakers
Fierce Pharma
Wed, 10/23/24 - 10:26 pm
Roche
Novo Holdings
Catalent
CDMOs
M&A
drug manufacturing
Merck sets sights on brain cancer with $30M Modifi acquisition
Fierce Biotech
Wed, 10/23/24 - 11:41 am
Merck
M&A
Modifi Biosciences
glioblastoma
brain cancer
Health insurance giants restart merger talks
Axios
Tue, 10/22/24 - 11:21 am
M&A
insurers
Cigna
Humana
Sanofi moves ahead with CD&R deal for stake in consumer business
BioPharma Dive
Mon, 10/21/24 - 11:40 pm
Sanofi
Opella
consumer health
M&A
Catalent CEO to remain in charge of contract drugmaker after Novo Holdings' buyout
Reuters
Mon, 10/21/24 - 09:41 am
Catalent
Alessandro Maselli
Novo Holdings
M&A
Sanofi reaches deal on terms of sale of consumer health arm, say French government sources
Reuters
Sun, 10/20/24 - 10:18 pm
Sanofi
M&A
Opella
consumer health
Novo Holdings' $16.5B Catalent buyout in crosshairs as consumer groups ask FTC to block the deal
Fierce Pharma
Fri, 10/18/24 - 11:26 am
Novo Holdings
Catalent
FTC
M&A

Pages